Taken together, these findings support the results of this study, reinforcing the proposition that HMGB1 participates in TLR4 spinal activation, triggering the production of inflammatory mediators involved with the nociception during PCT-induced neuropathic pain. This evidence concerns the gene TLR4 and neuropathic pain.